Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1) is a gene segment encoding a variable region of the immunoglobulin heavy chain, which is part of the antigen-binding site in human antibodies[1]. It participates in generating the diverse repertoire of antibodies produced by B lymphocytes through somatic recombination (V-(D)-J rearrangement), which is essential for the adaptive immune system’s ability to recognize a wide range of antigens[1][2]. IGHV7-4-1 is expressed at low levels compared to other immunoglobulin heavy variable genes and may have reduced capacity to produce functional products due to an unusual cysteine residue at position 92, potentially compromising the structure or stability of antibodies derived from this segment[2]. This gene is not a receptor, enzyme, or typical therapeutic target by itself, but rather a genetic element contributing to antibody diversity[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1).